2026.Jun.11

Corporate

OBI Presents Three Featured Talks at the 2026 World ADC Summit South Korea
Highlighting GlycOBI® and Dual-Payload ADC Technologies

Taipei, Taiwan, June 11, 2026 —OBI Pharma, Inc. (4174.TWO), a leader in innovative biopharmaceuticals, successfully delivered three featured presentations at the 5th World ADC Summit South Korea in Seoul.

HOMEWhat’s NewNewsOBI Presents Three Featured Talks at the 2026 World ADC Summit South Korea Highlighting GlycOBI® and Dual-Payload ADC Technologies

Back to List

This article is password protected.

To view the content, please enter your password in the field below

2026.Apr.24

OBI Announces US FDA Registration and Activation of HYProtecan™ Type II Drug Master File Supporting Obrion Engine™ ADC Technologies and Enhancing Regulatory Efficiency